Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report of the
study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03444584” into the search box, and
click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00007” into the search box, and click “Find a Study”.
Full study title: An Exploratory Phase 2a Randomized, Placebo-controlled, Double blind Study
to Evaluate the Efficacy and Safety of MEDI0382 versus Placebo in Overweight/Obese Subjects
with Type 2 Diabetes Mellitus Treated with Dapagliflozin and Metformin
AstraZeneca Protocol Number: D5670C00007
MedImmune, an AstraZeneca company, sponsored this study and has its headquarters in
Cambridge, UK.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical research
around the world. They help researchers answer important health questions and find medical
treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting participants for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
Version 1.5 2020_05_01